Recently, Lykos petitioned the FDA to approve the psychedelic MDMA for treatment-resistant PTSD, met with rejection by an advisory committee, leaving the final decision to the FDA.
Dr. Dave Rabin is advocating for psychedelic-assisted therapy, emphasizing positive outcomes seen from trials, yet awaiting FDA's final decision on the matter.
Collection
[
|
...
]